BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Manitoba//UMFOD Calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:6aa6b3b9a4ff8@umanitoba.ca
SUMMARY:Diagnosis and Risk Factors for Invasive Mold Infections - Internal Deadline
DESCRIPTION:Diagnosis and Risk Factors for Invasive Mold Infections\n\nThis competitive program seeks to encourage organizations to submit grant applications for independent educational activities for health care professionals involved in the diagnosis and management of patients with invasive fungal infections (IFI).\n\nPotential applicants are encouraged to address the educational needs of healthcare professionals relating to early diagnosis of invasive mold and yeast infections to improve the management of patients with IFI. This can include: • Needs assessment to better understand, assess and identify knowledge gaps and opportunities for action in diagnosis and testing including understanding of risk factors. • Educational tools/resources to reduce information barriers and knowledge acquisition. • Educational programs to improve knowledge comprehension and ensure equitable access and improved patient outcomes.\n\nIndividual projects requesting up to $75,000 will be considered. Pfizer anticipates awarding 5 projects.\n\n\nInternal Application Deadline: Sep 12, 2024 4:30 pm CST\n\nUMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=3687\n\nProgram URL: https://cdn.pfizer.com/pfizercom/2024-08/GMG-2024-HOS-Global-InvasiveFungalInfections-IME.pdf?VersionId=Y9vdonjMyIFgD9wqkPb1gqAjRiOgRIa3\nInternal Deadline
X-ALT-DESC;FMTTYPE=text/html:Diagnosis and Risk Factors for Invasive Mold Infections
This competitive program seeks to encourage organizations to submit grant applications for independent educational activities for health care professionals involved in the diagnosis and management of patients with invasive fungal infections (IFI).
Potential applicants are encouraged to address the educational needs of healthcare professionals relating to early diagnosis of invasive mold and yeast infections to improve the management of patients with IFI. This can include: • Needs assessment to better understand\, assess and identify knowledge gaps and opportunities for action in diagnosis and testing including understanding of risk factors. • Educational tools/resources to reduce information barriers and knowledge acquisition. • Educational programs to improve knowledge comprehension and ensure equitable access and improved patient outcomes.
Individual projects requesting up to $75\,000 will be considered. Pfizer anticipates awarding 5 projects.
Internal Application Deadline: Sep 12\, 2024 4:30 pm CST
UMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=3687
Program URL: https://cdn.pfizer.com/pfizercom/2024-08/GMG-2024-HOS-Global-InvasiveFungalInfections-IME.pdf?VersionId=Y9vdonjMyIFgD9wqkPb1gqAjRiOgRIa3
DTSTART:20240912T083000
DTEND:20240912T093000
BEGIN:VALARM
TRIGGER:-P2D
ACTION:DISPLAY
DESCRIPTION:Reminder for Diagnosis and Risk Factors for Invasive Mold Infections
END:VALARM
END:VEVENT
END:VCALENDAR